4.4 Review

Role of the Circadian Clock in the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease

Journal

DIGESTIVE DISEASES AND SCIENCES
Volume 63, Issue 12, Pages 3187-3206

Publisher

SPRINGER
DOI: 10.1007/s10620-018-5242-x

Keywords

Circadian rhythm; Fatty liver; Nonalcoholic steatohepatitis; Obesity; Diabetes mellitus

Ask authors/readers for more resources

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in industrialized nations and is strongly associated with the metabolic syndrome. The prevalence of NAFLD continues to rise along with the epidemic of the metabolic syndrome. Metabolic homeostasis is linked to the circadian clock (rhythm), with multiple signaling pathways in organs regulated by circadian clock genes, and recent studies of circadian clock gene functions suggest that disruption of the circadian rhythm is associated with significant morbidity and mortality, including the metabolic syndrome. In the industrialized world, various human behaviors and activities such as work and eating patterns, jet lag, and sleep deprivation interfere with the circadian rhythm, leading to perturbations in metabolism and development of the metabolic syndrome. In this review, we discuss how disruption of the circadian rhythm is associated with various metabolic conditions that comprise the metabolic syndrome and NAFLD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

Performance of the Liver Maximum Function Capacity Test, Fibrinogen, and Transient Elastography in Patients with Acute Liver Injury

Henriette Kreimeyer, Matthias Buechter, Jan Best, Robert K. Gieseler, Antonios Katsounas, Jan-Peter Sowa, Guido Gerken, Ali Canbay, Paul Manka, Lars P. Bechmann

Summary: This study aimed to evaluate the impact of liver maximum function capacity test (LiMAx) and coagulation factors on the prognosis of patients with acute liver failure (ALF). The results showed that LiMAx and fibrinogen may be effective indicators for predicting the survival rate of patients with nonacetaminophen-induced ALF, and they could be useful tools to assist in the decision-making process for liver transplantation.

DIGESTIVE DISEASES (2023)

Article Medicine, General & Internal

Effects of Moderate Alcohol Consumption in Non-Alcoholic Fatty Liver Disease

Peter Lemmer, Paul Manka, Jan Best, Alisan Kahraman, Julia Kaelsch, Ramiro Vilchez-Vargas, Alexander Link, Hsin Chiang, Guido Gerken, Ali Canbay, Lars P. Bechmann, Svenja Sydor

Summary: Alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD) are leading causes of chronic liver diseases worldwide. While clinically distinguished by alcohol consumption, NAFLD coexists with moderate alcohol consumption in a growing proportion of the population. Studies have shown that even moderate alcohol consumption has impacts on liver injury, lipid metabolism, and the composition of gut microbiota.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Biochemistry & Molecular Biology

A Potential Role for Bile Acid Signaling in Celiac Disease-Associated Fatty Liver

Paul Manka, Svenja Sydor, Julia M. Schaenzer-Ocklenburg, Malte Brandenburg, Jan Best, Ramiro Vilchez-Vargas, Alexander Link, Dominik Heider, Susanne Brodesser, Anja Figge, Andreas Jaehnert, Jason D. Coombes, Francisco Javier Cubero, Alisan Kahraman, Moon-Sung Kim, Julia Kaelsch, Sonja Kinner, Klaas Nico Faber, Han Moshage, Guido Gerken, Wing-Kin Syn, Ali Canbay, Lars P. Bechmann

Summary: Even in CeD patients in clinical remission under a gluten-free diet, alterations in gut-liver axis, especially bile acid signaling, may contribute to steatotic liver injury.

METABOLITES (2022)

Letter Gastroenterology & Hepatology

Non-Invasive Risk Stratification in NAFLD/NASH Patients for Screening EGD

John Romano, Thaer Abdelfattah, Paul P. Manka, Michael Fuchs, Wing-Kin Syn

CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2022)

Article Biochemistry & Molecular Biology

Discovering Biomarkers for Non-Alcoholic Steatohepatitis Patients with and without Hepatocellular Carcinoma Using Fecal Metaproteomics

Svenja Sydor, Christian Dandyk, Johannes Schwerdt, Paul Manka, Dirk Benndorf, Theresa Lehmann, Kay Schallert, Maximilian Wolf, Udo Reichl, Ali Canbay, Lars P. Bechmann, Robert Heyer

Summary: High-calorie diets can lead to liver diseases and disruptions in the gut microbiome. Analyzing medical parameters and fecal metaproteome can help identify biomarkers for diagnosing non-alcoholic fatty liver disease (NAFLD) and hepatocellular carcinoma (HCC). Machine learning algorithms achieved high accuracy in distinguishing between healthy controls, NASH, and HCC.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Oncology

LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver Cirrhosis

Catherine Leyh, Niklas Heucke, Clemens Schotten, Matthias Buechter, Lars P. Bechmann, Marc Wichert, Alexander Dechene, Ken Herrmann, Dominik Heider, Svenja Sydor, Peter Lemmer, Johannes M. Ludwig, Josef Pospiech, Jens Theysohn, Robert Damm, Christine March, Maciej Powerski, Maciej Pech, Mustafa Oezcueruemez, Jochen Weigt, Verena Keitel, Christian M. Lange, Hartmut Schmidt, Ali Canbay, Jan Best, Guido Gerken, Paul P. Manka

Summary: LiMAx (R) is a non-invasive test that has the potential to predict post-interventional hepatic decompensation after radioembolization (RE) for hepatocellular carcinoma (HCC). Patients with lower baseline LiMAx (R) values have a higher risk of hepatic decompensation after RE.

CANCERS (2022)

Article Multidisciplinary Sciences

Loss of GPR40 in LDL receptor-deficient mice exacerbates high-fat diet-induced hyperlipidemia and nonalcoholic steatohepatitis

Zhongyang Lu, Yanchun Li, Ai-Jun Li, Wing-Kin Syn, Stephen A. Wank, Maria F. Lopes-Virella, Yan Huang

Summary: This study demonstrated for the first time that loss of GPR40 in LDLR-deficient mice exacerbated HFD-induced hyperlipidemia, hepatic steatosis, inflammation, and fibrosis potentially through a CD36-dependent mechanism, suggesting that GPR40 may play a beneficial role in hyperlipidemia-associated NASH in LDLR-deficient mice.

PLOS ONE (2022)

Article Gastroenterology & Hepatology

Comparison of age- and sex-dependent reference limits derived from distinct sources for metabolic measurands in basic liver diagnostics

Martina Broecker-Preuss, Farhad Arzideh, Jan Best, Ali Canbay, Mustafa oezcueruemez, Paul Manka

Summary: Current reference intervals for basic liver laboratory diagnosis rely on manufacturers' information, ignoring known age and sex dependencies. By comparing the age-dependent distribution of flagged and non-flagged laboratory findings between different reference limits, we found notable differences. We suggest further analysis of the diagnostic and economic effects of reference limits adapted to the population of interest for liver diagnostics.

ZEITSCHRIFT FUR GASTROENTEROLOGIE (2023)

Biographical-Item Gastroenterology & Hepatology

Obituary of adjunct Professor Dr. med. Lars Peter Bechmann 22.09.1977 in Hagen, Westphalia to 01.07.2022 in Melle

Ali E. Canbay, Jan Best, Paul Manka

ZEITSCHRIFT FUR GASTROENTEROLOGIE (2022)

Editorial Material Gastroenterology & Hepatology

Liver, Heart, Death horizontal ellipsis Can This Sequence Be Broken?

Paul Manka

DIGESTIVE DISEASES AND SCIENCES (2023)

Article Gastroenterology & Hepatology

Thyroid hormone receptor alpha modulates fibrogenesis in hepatic stellate cells

Paul Manka, Jason D. Coombes, Svenja Sydor, Marzena K. Swiderska-Syn, Jan Best, Karine Gauthier, Leo A. van Grunsven, Ye H. Oo, Cindy Wang, Anna M. Diehl, Georg S. Hoenes, Lars C. Moeller, Anja Figge, Rene J. Boosman, Klaas N. Faber, Andrea Tannapfel, Oliver Goetze, Patricia Aspichueta, Christian M. Lange, Ali Canbay, Wing-Kin Syn

Summary: Thyroid hormones play a crucial role in hepatic fibrogenesis by regulating the phenotype of hepatic stellate cells (HSC) via the TGF beta signaling pathway. In vitro experiments showed that T3 can inhibit the expression of fibrogenic genes and promote wound healing in HSC. In vivo experiments on TR alpha-deficient mice further confirmed the importance of the TH-TR axis in liver fibrosis.

LIVER INTERNATIONAL (2023)

Meeting Abstract Gastroenterology & Hepatology

Effects of a one-month consumption of different non-alcoholic beers on metabolic and liver health in young men

Henriette Kreimeyer, Svenja Sydor, Lara Kaiser, Cagatay Toskal, Anja Figge, Jan Best, Josef Pospiech, Oliver Goetze, Jan-Peter Sowa, Mustafa Oezcueruemez, Ali Canbay, Lars Bechmann, Paul Manka

JOURNAL OF HEPATOLOGY (2023)

Article Urology & Nephrology

Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease Cross Talk

Jacob Nysather, Eda Kaya, Paul Manka, Prakash Gudsoorkar, Wing-Kin Syn

Summary: Nonalcoholic fatty liver disease and chronic kidney disease share pathophysiological mechanisms and treatment strategies.

ADVANCES IN KIDNEY DISEASE AND HEALTH (2023)

Meeting Abstract Gastroenterology & Hepatology

Type 2 diabetes and religious fasting: effects on metabolism and liver steatosis

Svenja Sydor, Ender Engin, Mustafa Oezcueruemez, Anja Figge, Josef Pospiech, Andreas Jaehnert, Jan Best, Wing-Kin Syn, Ali Canbay, Lars Bechmann, Paul Manka

JOURNAL OF HEPATOLOGY (2022)

Meeting Abstract Gastroenterology & Hepatology

LiMAx faciliates patient selection prior radioembolization for patients with hepatocellular carcinoma in liver cirrhosis

Catherine Leyh, Niklas Heucke, Clemens Schotten, Matthias Buechter, Lars Bechmann, Marc Wichert, Alexander Dechene, Ken Hermann, Antonios Katsounas, Mustafa Ozcurumez, Dominik Heider, Svenja Sydor, Johannes M. Ludwig, Jens Theysohn, Robert Damm, Maciej Powerski, Maciej Pech, Ali Canbay, Jochen Weigt, Verena Keitel-Anselmino, Christian Lange, Jan Best, Paul Manka

JOURNAL OF HEPATOLOGY (2022)

No Data Available